Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcesscell morphogenesis

HGF L1CAM MBP ADGRB1 GAS7 POU4F2 PRAG1 JMJD1C ATL1 CASK NRXN3 FEZ1 ARL13B LRP1 AUTS2 LEF1 MAP4K4 SLC9A6 MOV10

8.43e-06119410519GO:0000902
GeneOntologyBiologicalProcesscell junction organization

ZNF703 ANK2 CACNA2D2 L1CAM ADGRB1 ZDHHC8 ELFN2 SHISA7 CASK NRXN3 NF1 LRP1 MAP4K4 SLC9A6 PDZRN3 TBX5

3.25e-0597410516GO:0034330
GeneOntologyBiologicalProcessnegative regulation of cell-substrate adhesion

CASK NF1 LRP1 PLG MAP4K4

3.79e-05741055GO:0010812
GeneOntologyBiologicalProcessneuron projection morphogenesis

L1CAM MBP ADGRB1 GAS7 POU4F2 ATL1 CASK NRXN3 FEZ1 LRP1 AUTS2 MAP4K4 SLC9A6 MOV10

5.56e-0580210514GO:0048812
GeneOntologyBiologicalProcessnegative regulation of cell-matrix adhesion

CASK NF1 LRP1 MAP4K4

6.72e-05431054GO:0001953
GeneOntologyBiologicalProcessplasma membrane bounded cell projection morphogenesis

L1CAM MBP ADGRB1 GAS7 POU4F2 ATL1 CASK NRXN3 FEZ1 LRP1 AUTS2 MAP4K4 SLC9A6 MOV10

6.96e-0581910514GO:0120039
GeneOntologyBiologicalProcesscell projection morphogenesis

L1CAM MBP ADGRB1 GAS7 POU4F2 ATL1 CASK NRXN3 FEZ1 LRP1 AUTS2 MAP4K4 SLC9A6 MOV10

7.62e-0582610514GO:0048858
GeneOntologyBiologicalProcessneuron projection development

HGF L1CAM MBP ADGRB1 GAS7 POU4F2 PRAG1 ATL1 CASK NRXN3 NF1 FEZ1 LRP1 AUTS2 MINAR1 MAP4K4 SLC9A6 MOV10

8.03e-05128510518GO:0031175
GeneOntologyBiologicalProcessregulation of cell projection organization

HGF L1CAM MBP POU4F2 PRAG1 CASK NF1 FEZ1 ADAMTS16 LRP1 AUTS2 MINAR1 MAP4K4 MOV10

1.21e-0486310514GO:0031344
GeneOntologyBiologicalProcessnegative regulation of cell adhesion

ZNF703 MBP CASK NF1 LRP1 ADAMTS18 TMEM131L PLG MAP4K4

1.28e-043751059GO:0007162
GeneOntologyBiologicalProcessneuron development

HGF L1CAM MBP ADGRB1 GAS7 POU4F2 PRAG1 ATL1 CASK NRXN3 NF1 FEZ1 PITX3 LRP1 AUTS2 MINAR1 MAP4K4 SLC9A6 MOV10

1.35e-04146310519GO:0048666
GeneOntologyBiologicalProcessdevelopmental cell growth

ANG L1CAM POU4F2 ADRA1A CTDP1 LRP1 AUTS2 SLC9A6

1.54e-043011058GO:0048588
GeneOntologyBiologicalProcessregulation of postsynaptic membrane neurotransmitter receptor levels

CACNA2D2 NRXN3 AP2B1 CLPTM1 LRP1 SLC9A6

1.94e-041641056GO:0099072
GeneOntologyBiologicalProcesschemokine (C-X-C motif) ligand 2 production

MBP OAS1 LRP1

2.40e-04241053GO:0072567
GeneOntologyBiologicalProcessregulation of chemokine (C-X-C motif) ligand 2 production

MBP OAS1 LRP1

2.40e-04241053GO:2000341
GeneOntologyBiologicalProcessformation of radial glial scaffolds

ARL13B LEF1

2.54e-0451052GO:0021943
GeneOntologyBiologicalProcessregulation of neuron projection development

HGF L1CAM MBP POU4F2 PRAG1 CASK NF1 FEZ1 LRP1 MINAR1 MAP4K4

2.87e-0461210511GO:0010975
GeneOntologyBiologicalProcessregulation of cell-substrate adhesion

L1CAM CASK ATXN3L NF1 LRP1 PLG MAP4K4

3.23e-042541057GO:0010810
GeneOntologyBiologicalProcesscirculatory system development

HGF ANG ANK2 ADGRB1 POU4F2 BCOR ADRA1A NRXN3 NF1 AP2B1 TLR3 ARL13B CTDP1 LRP1 MINAR1 PLG LEF1 TBX5

3.36e-04144210518GO:0072359
GeneOntologyBiologicalProcessregulation of plasma membrane bounded cell projection organization

HGF L1CAM MBP POU4F2 PRAG1 CASK NF1 FEZ1 ADAMTS16 LRP1 AUTS2 MINAR1 MAP4K4

3.63e-0484610513GO:0120035
DomainMULTICOPPER_OXIDASE2

HEPH HEPHL1

9.36e-0531052PS00080
DomainCu-oxidase_2

HEPH HEPHL1

1.86e-0441052IPR011706
DomainCu-oxidase_2

HEPH HEPHL1

1.86e-0441052PF07731
DomainCu-oxidase_3

HEPH HEPHL1

3.10e-0451052IPR011707
DomainMULTICOPPER_OXIDASE1

HEPH HEPHL1

3.10e-0451052PS00079
DomainPAN_AP

HGF PLG

3.10e-0451052SM00473
DomainCu_oxidase_CS

HEPH HEPHL1

3.10e-0451052IPR033138
DomainCu-oxidase_3

HEPH HEPHL1

3.10e-0451052PF07732
DomainCu_oxidase_Cu_BS

HEPH HEPHL1

4.63e-0461052IPR002355
DomainPan_app

HGF PLG

6.45e-0471052IPR003609
DomainPAN

HGF PLG

6.45e-0471052PS50948
DomainPAN_1

HGF PLG

6.45e-0471052PF00024
Pubmed

An improved smaller biotin ligase for BioID proximity labeling.

ZNF703 TCF20 ASH1L BCOR JMJD1C SALL2

2.74e-06123110626912792
Pubmed

An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.

TCF20 NEDD1 JMJD1C ATL1 JPH1 ZCCHC14 FAM120A CLPTM1 TMEM131L MAP4K4 PDZRN3 ITPRIPL1

3.75e-067331101234672954
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

GAS7 ELFN2 JMJD1C FAM120A POP1 ADAMTS16 LPGAT1 MINAR1 PDZRN3 MOV10

3.96e-064931101015368895
Pubmed

The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.

ZNF703 BICRA BCOR SPATA2 JMJD1C AUTS2

9.30e-06152110638360978
Pubmed

Obesity and High-Fat Diet Induce Distinct Changes in Placental Gene Expression and Pregnancy Outcome.

ANG ADGRB1 TLR3 PLG

9.66e-0642110429438518
Pubmed

ANK2 autism mutation targeting giant ankyrin-B promotes axon branching and ectopic connectivity.

ANK2 L1CAM

9.91e-062110231285321
Pubmed

Hepatocyte growth factor activates Wnt pathway by transcriptional activation of LEF1 to facilitate tumor invasion.

HGF LEF1

9.91e-062110222436613
Pubmed

Nervous system defects of AnkyrinB (-/-) mice suggest functional overlap between the cell adhesion molecule L1 and 440-kD AnkyrinB in premyelinated axons.

ANK2 L1CAM

9.91e-06211029832558
Pubmed

Myelin basic protein cleaves cell adhesion molecule L1 and promotes neuritogenesis and cell survival.

L1CAM MBP

9.91e-062110224671420
Pubmed

L1-dependent neuritogenesis involves ankyrinB that mediates L1-CAM coupling with retrograde actin flow.

ANK2 L1CAM

9.91e-062110214657231
Pubmed

Myelin Basic Protein Cleaves Cell Adhesion Molecule L1 and Improves Regeneration After Injury.

L1CAM MBP

9.91e-062110226081148
Pubmed

Evaluation of ADAMTS12, ADAMTS16, ADAMTS18 and IL-33 serum levels in pre-eclampsia.

ADAMTS16 ADAMTS18

9.91e-062110226382559
Pubmed

TLR3 promotes hepatocyte proliferation after partial hepatectomy by stimulating uPA expression and the release of tissue-bound HGF.

HGF TLR3

9.91e-062110232539223
Pubmed

The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.

ANK2 MBP OAS1 ZDHHC8 CCNY CASK JPH1 NF1 ARL13B MAP4K4

1.38e-055691101030639242
Pubmed

RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.

TCF20 CCDC85C NEDD1 ZDHHC8 JMJD1C TMEM131L MAP4K4

2.14e-05263110734702444
Pubmed

Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.

ADGRB1 GAS7 ZDHHC8 CASK JPH1 NF1 ARL13B MAP4K4

2.77e-05377110838117590
Pubmed

Characterisation of the interaction between syndecan-2, neurofibromin and CASK: dependence of interaction on syndecan dimerization.

CASK NF1

2.97e-053110220006588
Pubmed

Bipartite interaction between neurofibromatosis type I protein (neurofibromin) and syndecan transmembrane heparan sulfate proteoglycans.

CASK NF1

2.97e-053110211356864
Pubmed

Postmortem genetic analysis of sudden unexplained death syndrome under 50 years of age: A next-generation sequencing study.

ANK2 TBX5

2.97e-053110227005929
Pubmed

[Ceruloplasmin, hephaestin and zyklopen: the three multicopper oxidases important for human iron metabolism].

HEPH HEPHL1

2.97e-053110224988611
Pubmed

Myelin basic protein stimulates plasminogen activation via tissue plasminogen activator following binding to independent l-lysine-containing domains.

MBP PLG

2.97e-053110228648598
Pubmed

Impaired OTUD7A-dependent Ankyrin regulation mediates neuronal dysfunction in mouse and human models of the 15q13.3 microdeletion syndrome.

ANK2 ADGRB1 ZDHHC8 ELFN2 SHISA7 MINAR1

4.02e-05197110636604605
Pubmed

Characterization and in vivo pharmacological rescue of a Wnt2-Gata6 pathway required for cardiac inflow tract development.

SALL2 LEF1 TBX5

5.21e-0523110320159597
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

ENPP6 BICRA HAUS5 ASH1L GAS7 SIK3 BCOR JPH1 SALL2 FAM120A LRP1 TIGD5 PDZRN3

5.32e-0511161101331753913
Pubmed

LZTR1 is a regulator of RAS ubiquitination and signaling.

HEPH GAB2 NF1 MAP4K4 HBZ

5.40e-05127110530442766
Pubmed

Increased plasmin-mediated proteolysis of L1CAM in a mouse model of idiopathic normal pressure hydrocephalus.

L1CAM PLG

5.92e-054110234380733
Pubmed

Molecular interactions of SHP1 and SHP2 in IL-3-signalling.

PILRB GAB2

5.92e-054110211812650
Pubmed

Abnormalities in neuronal process extension, hippocampal development, and the ventricular system of L1 knockout mice.

L1CAM MBP

5.92e-054110210366625
Pubmed

CASK: a novel dlg/PSD95 homolog with an N-terminal calmodulin-dependent protein kinase domain identified by interaction with neurexins.

CASK NRXN3

5.92e-05411028786425
Pubmed

Giant ankyrin-B mediates transduction of axon guidance and collateral branch pruning factor sema 3A.

ANK2 L1CAM

5.92e-054110234812142
Pubmed

Myelin deficient, a new neurological mutant in the mouse.

CACNA2D2 MBP

5.92e-0541102599283
Pubmed

Glycosaminoglycan-binding properties and aggrecanase activities of truncated ADAMTSs: comparative analyses with ADAMTS-5, -9, -16 and -18.

ADAMTS16 ADAMTS18

5.92e-054110216507336
Pubmed

Myelination triggers local loss of axonal CNR/protocadherin alpha family protein expression.

L1CAM MBP

5.92e-054110215579137
Pubmed

Cellular Origin, Tumor Progression, and Pathogenic Mechanisms of Cutaneous Neurofibromas Revealed by Mice with Nf1 Knockout in Boundary Cap Cells.

L1CAM MBP NF1

5.94e-0524110330348676
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

CACNA2D2 BICRA MBP ASH1L CCDC85C CHD2 NEDD1 JMJD1C CCNY NBPF1 CASK FAM120A ZNF33B LRP1 AUTS2

7.14e-0514891101528611215
Pubmed

Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.

SIK3 HEPH ZCCHC14 SALL2 AUTS2 MINAR1

8.39e-05225110612168954
Pubmed

Osteocyte transcriptome mapping identifies a molecular landscape controlling skeletal homeostasis and susceptibility to skeletal disease.

SKIDA1 ZCCHC14 AUTS2

9.52e-0528110333953184
Pubmed

L1-mediated branching is regulated by two ezrin-radixin-moesin (ERM)-binding sites, the RSLE region and a novel juxtamembrane ERM-binding region.

ANK2 L1CAM

9.85e-055110215647482
Pubmed

Subcellular localization of coagulation factor II receptor-like 1 in neurons governs angiogenesis.

ANG POU4F2

9.85e-055110225216639
Pubmed

Angiogenin interacts with the plasminogen activation system at the cell surface of breast cancer cells to regulate plasmin formation and cell migration.

ANG PLG

9.85e-055110224457100
Pubmed

Regulation of the murine Ddelta2 promoter by upstream stimulatory factor 1, Runx1, and c-Myb.

NF1 LEF1

9.85e-055110215778374
Pubmed

Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein induce Akt phosphorylation in the ischemic brain.

LRP1 PLG

9.85e-055110218628488
Pubmed

The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.

TCF20 L1CAM CCDC85C CHD2 DDB2 JMJD1C ATL1 CCNY CLPTM1 LRP1 AUTS2 LPGAT1 PLRG1

1.13e-0412031101329180619
Pubmed

Secondary Placental Defects in Cxadr Mutant Mice.

HGF ANG MEST

1.43e-0432110331338035
Pubmed

Chikungunya virus infection induces differential inflammatory and antiviral responses in human monocytes and monocyte-derived macrophages.

OAS1 TLR3

1.47e-046110232634389
Pubmed

RA-GEF-1 (Rapgef2) is essential for proper development of the midline commissures.

L1CAM MBP

1.47e-046110221864586
Pubmed

The low-density lipoprotein receptor-related protein 1 mediates tissue-type plasminogen activator-induced microglial activation in the ischemic brain.

LRP1 PLG

1.47e-046110219147818
Pubmed

Ep400 deficiency in Schwann cells causes persistent expression of early developmental regulators and peripheral neuropathy.

ANK2 MBP

1.47e-046110231142747
Pubmed

Presynaptic α2δ-2 Calcium Channel Subunits Regulate Postsynaptic GABAA Receptor Abundance and Axonal Wiring.

CACNA2D2 NRXN3

1.47e-046110230683685
Pubmed

STAT3 Controls the Long-Term Survival and Phenotype of Repair Schwann Cells during Nerve Regeneration.

L1CAM MBP

1.47e-046110228320842
Pubmed

Sarm1, a negative regulator of innate immunity, interacts with syndecan-2 and regulates neuronal morphology.

CASK NF1

1.47e-046110221555464
Pubmed

Docking protein Gab1 is an essential component of postnatal angiogenesis after ischemia via HGF/c-met signaling.

HGF GAB2

1.47e-046110221293003
Pubmed

Eomesodermin, a target gene of Pou4f2, is required for retinal ganglion cell and optic nerve development in the mouse.

POU4F2 TBX5

1.47e-046110218077589
Pubmed

Expression of the tight junction protein ZO-1 in the olfactory system: presence of ZO-1 on olfactory sensory neurons and glial cells.

L1CAM MBP

1.47e-04611028201022
Pubmed

Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.

ZNF487 GALNT1 C5orf63 ASH1L OAS1 CHD2 BCOR MEST POP1 ADAMTS18 TMEM131L FUCA2

1.68e-0410841101211544199
Pubmed

Pax3: a paired domain gene as a regulator in PNS myelination.

L1CAM MBP

2.06e-04711027546735
Pubmed

Cloning, expression analysis, and structural characterization of seven novel human ADAMTSs, a family of metalloproteinases with disintegrin and thrombospondin-1 domains.

ADAMTS16 ADAMTS18

2.06e-047110211867212
Pubmed

Segregation of ipsilateral retinal ganglion cell axons at the optic chiasm requires the Shh receptor Boc.

L1CAM POU4F2

2.06e-047110220053908
Pubmed

GPR84 Is Essential for the Taste of Medium Chain Saturated Fatty Acids.

MBP PTPRU

2.06e-047110233941648
Pubmed

Endocardial Brg1 represses ADAMTS1 to maintain the microenvironment for myocardial morphogenesis.

MEST ADAMTS18 TBX5

2.40e-0438110318267097
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

TCF20 ANK2 SIK3 BCOR SHISA7 CASK NF1 FAM120A AP2B1 LRP1 MAP4K4

2.44e-049631101128671696
Pubmed

Altered White Matter and microRNA Expression in a Murine Model Related to Williams Syndrome Suggests That miR-34b/c Affects Brain Development via Ptpru and Dcx Modulation.

MBP PTPRU

2.74e-048110235011720
Pubmed

Expression of Interferon-Stimulated Genes in Insulitic Pancreatic Islets of Patients Recently Diagnosed With Type 1 Diabetes.

OAS1 TLR3

2.74e-048110227422384
Pubmed

Primary cilia are WNT-transducing organelles whose biogenesis is controlled by a WNT-PP1 axis.

CCNY ARL13B

2.74e-048110236693320
Pubmed

Primary cilia control oligodendrocyte precursor cell proliferation in white matter injury via Hedgehog-independent CREB signaling.

MBP ARL13B

2.74e-048110237858465
Pubmed

An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.

ZNF703 TCF20 BCOR JMJD1C PITX3

2.77e-04180110535198878
Pubmed

Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.

ANK2 SIK3 PRAG1 SHISA7 NF1 AP2B1

2.80e-04281110628706196
Pubmed

Identification and functional characterization of transcriptional activators in human cells.

ZNF703 TCF20 BICRA BCOR JMJD1C AUTS2 MYO15A

2.82e-04398110735016035
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

HAUS5 SIK3 BCOR HEPH NRXN3 AUTS2 TMEM131L MAP4K4

2.87e-04529110814621295
Pubmed

Reprogramming amacrine and photoreceptor progenitors into retinal ganglion cells by replacing Neurod1 with Atoh7.

POU4F2 NRXN3

3.52e-049110223293286
Pubmed

Dual phosphorylation of phosphoinositide 3-kinase adaptor Grb2-associated binder 2 is responsible for superoxide formation synergistically stimulated by Fc gamma and formyl-methionyl-leucyl-phenylalanine receptors in differentiated THP-1 cells.

MBP GAB2

3.52e-049110214530346
Pubmed

Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.

CACNA2D2 GAB2 ZCCHC14 NRXN3

3.54e-0410511049628581
Pubmed

The DNA sequence and analysis of human chromosome 14.

CCDC85C RBM23 ATL1 NRXN3

4.37e-04111110412508121
Pubmed

Neuropilin-2 regulates the development of selective cranial and sensory nerves and hippocampal mossy fiber projections.

MBP LEF1

4.39e-0410110210707971
Pubmed

Essential role for the Prader-Willi syndrome protein necdin in axonal outgrowth.

L1CAM FEZ1

4.39e-0410110215649943
Pubmed

The role of hereditary spastic paraplegia related genes in multiple sclerosis. A study of disease susceptibility and clinical outcome.

L1CAM ATL1

4.39e-0410110217420921
Pubmed

Evolutionary history and genome organization of DUF1220 protein domains.

NBPF12 NBPF1

4.39e-0410110222973535
Pubmed

MyoR modulates cardiac conduction by repressing Gata4.

CACNA2D2 TBX5

4.39e-0410110225487574
Pubmed

MUC20 suppresses the hepatocyte growth factor-induced Grb2-Ras pathway by binding to a multifunctional docking site of met.

HGF GAB2

4.39e-0410110215314156
Pubmed

Loss of histone methyltransferase ASH1L in the developing mouse brain causes autistic-like behaviors.

MBP ASH1L

4.39e-0410110234145365
Pubmed

DZIP1 regulates mammalian cardiac valve development through a Cby1-β-catenin mechanism.

ARL13B LEF1

5.35e-0411110233811421
Pubmed

High levels of structural disorder in scaffold proteins as exemplified by a novel neuronal protein, CASK-interactive protein1.

L1CAM CASK

5.35e-0411110219523119
Pubmed

Hyperactivation of p21(ras) and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro.

MBP NF1

5.35e-0411110211435472
Pubmed

The augmin complex plays a critical role in spindle microtubule generation for mitotic progression and cytokinesis in human cells.

HAUS5 NEDD1

5.35e-0411110219369198
Pubmed

Periostin as a biomarker of the amniotic membrane.

HBZ TBX5

5.35e-0411110222966238
Pubmed

Prediction of the coding sequences of unidentified human genes. VIII. 78 new cDNA clones from brain which code for large proteins in vitro.

KIAA0408 GAS7 AUTS2

6.08e-045211039455477
Pubmed

Genetic analysis of genes involved in amyloid-β degradation and clearance in Alzheimer's disease.

LRP1 PLG

6.41e-0412110222027013
Pubmed

Tbx5 is essential for forelimb bud initiation following patterning of the limb field in the mouse embryo.

LEF1 TBX5

6.41e-0412110212490567
Pubmed

Neuronal miR-17-5p contributes to interhemispheric cortical connectivity defects induced by prenatal alcohol exposure.

L1CAM MBP

6.41e-0412110237610874
Pubmed

Proteomic analysis of in vivo phosphorylated synaptic proteins.

MBP ATL1 CCNY

6.43e-0453110315572359
Pubmed

Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability.

ZDHHC8 ATL1 CCNY JPH1 NF1 ARL13B MAP4K4

7.30e-04467110730194290
Pubmed

The ciliary GTPase Arl3 maintains tissue architecture by directing planar spindle orientation during epidermal morphogenesis.

ARL13B LEF1

7.56e-0413110230952667
Pubmed

Differential impacts of Cntnap2 heterozygosity and Cntnap2 null homozygosity on axon and myelinated fiber development in mouse.

L1CAM MBP

7.56e-0413110236793543
Pubmed

Mammary gland, limb and yolk sac defects in mice lacking Tbx3, the gene mutated in human ulnar mammary syndrome.

LEF1 TBX5

7.56e-0413110212668638
Pubmed

Gorab Is Required for Dermal Condensate Cells to Respond to Hedgehog Signals during Hair Follicle Morphogenesis.

ARL13B LEF1

7.56e-0413110226967474
Pubmed

Control of glial precursor cell development in the mouse optic nerve by sonic hedgehog from retinal ganglion cells.

MBP POU4F2

7.56e-0413110218625210
Pubmed

Transdifferentiation of the ventral retinal pigmented epithelium to neural retina in the growth arrest specific gene 1 mutant.

L1CAM TBX5

7.56e-0413110211456441
Pubmed

ISL1 and BRN3B co-regulate the differentiation of murine retinal ganglion cells.

L1CAM POU4F2

7.56e-0413110218434421
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

ANK2 ASH1L GAS7 CASK JPH1 FAM120A AP2B1 FEZ1 ARL13B LRP1 REPS2 MAP4K4

7.72e-0412851101235914814
Pubmed

Mice lacking DYRK2 exhibit congenital malformations with lung hypoplasia and altered Foxf1 expression gradient.

CACNA2D2 HBZ TBX5

7.95e-0457110334671097
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ENPP6 HGF ANK2 GAS7 ADRA1A PXDNL LRP1 PDZRN3 TBX5

1.19e-091911109b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCellLPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ENPP6 ANK2 GAS7 CPZ ADRA1A FEZ1 PXDNL LRP1 PDZRN3

1.25e-091921109f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ENPP6 ANK2 CPZ ADRA1A FEZ1 PXDNL LRP1 PDZRN3 TBX5

1.25e-091921109dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCellLPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ENPP6 HGF ANK2 GAS7 ADRA1A PXDNL LRP1 PDZRN3 TBX5

1.25e-091921109deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ENPP6 HGF ANK2 ADRA1A PXDNL LRP1 PDZRN3 TBX5

2.68e-0819211086f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ENPP6 HGF ANK2 ADRA1A PXDNL LRP1 PDZRN3 TBX5

2.79e-081931108fb28717fadd06c3840636d25409ce80c9254bd34
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ENPP6 HGF ANK2 ADRA1A PXDNL LRP1 PDZRN3 TBX5

2.91e-08194110860622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

KIAA0408 ENPP6 HGF ANK2 PXDNL LRP1 PDZRN3 TBX5

3.54e-08199110830d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

ENPP6 HGF ANK2 CPZ PXDNL LRP1 PDZRN3 TBX5

3.54e-081991108e1849505b92820a219c5a2c35492bdd55579fb48
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

ENPP6 HGF ANK2 CPZ PXDNL LRP1 PDZRN3 TBX5

3.68e-082001108b79628fd1386aa9a3b0e9fa81def0bc100c3c073
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

ENPP6 HGF ANK2 CPZ PXDNL LRP1 PDZRN3 TBX5

3.68e-08200110850ca6550998e461ef26dd670351060bd940765a8
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

ENPP6 HGF ANK2 CPZ PXDNL LRP1 PDZRN3 TBX5

3.68e-0820011083bdba9612cd7c612b76aa9abecc4a6529aabfc1c
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

ENPP6 HGF ANK2 CPZ PXDNL LRP1 PDZRN3 TBX5

3.68e-08200110844a68bacdb3d5bf563bd35952176995850933a81
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

ENPP6 HGF ANK2 CPZ PXDNL LRP1 PDZRN3 TBX5

3.68e-082001108dc61016c61729f69649cfb21f6264e685ce83dea
ToppCellPND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass

PAPPA2 ANK2 PRAG1 JPH1 NRXN3 PDZRN3 TBX5

3.95e-071851107427176ad9ab8d9511200fb0a132cfd1e835fe35c
ToppCellhuman_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

TCF20 CEP128 MEST NRXN3 ADAMTS18 LEF1 PDZRN3

4.40e-071881107b070a0667f1ee9b825b267b6c389b7c42fc436f9
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ENPP6 ANK2 CPZ FEZ1 PXDNL LRP1 PDZRN3

4.56e-071891107a153b83314cf52808f685296cff8c95af3f4983d
ToppCellLPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ENPP6 CPZ ADRA1A FEZ1 PXDNL LRP1 PDZRN3

4.56e-071891107e9d5e858e320c6e9913c1ea6a54967d21eda605f
ToppCellLPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ENPP6 HGF ANK2 PXDNL LRP1 PDZRN3 TBX5

4.56e-0718911072a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCellLPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ENPP6 HGF CPZ MEST FEZ1 LRP1 PDZRN3

4.73e-071901107d60395739458d7f47a3350ade751fe3819500320
ToppCellLPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ENPP6 ANK2 CPZ ADRA1A FEZ1 LRP1 PDZRN3

5.07e-071921107df1545670370fb1010c567cd059c2783eab315f7
ToppCellLPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ENPP6 ANK2 CPZ FEZ1 LRP1 PDZRN3 TBX5

5.07e-071921107162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ENPP6 HGF ANK2 PXDNL LRP1 PDZRN3 TBX5

5.07e-0719211073d0cb19f037f604253d7d728689aeaa94251e92b
ToppCellLPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ENPP6 ANK2 CPZ FEZ1 LRP1 PDZRN3 TBX5

5.07e-0719211074e47a02007f562f29ba5910df64d32a0167d0bd1
ToppCellwk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

CPZ PRAG1 LEF1 SLC9A6 PDZRN3 DISP1 TBX5

5.25e-0719311072f203f6f0c2135acb046c9351a633c3b5b254a46
ToppCellLPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ENPP6 ANK2 FEZ1 PXDNL LRP1 PDZRN3 TBX5

5.44e-0719411076e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ENPP6 ANK2 GAS7 PXDNL LRP1 PDZRN3 TBX5

5.44e-07194110789b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCellE18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CYP2E1 PRAG1 JPH1 NRXN3 LEF1 PDZRN3 TBX5

5.63e-071951107b0d408f8bc1701a87596ed55efcd90749fee33e6
ToppCellE18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CYP2E1 PRAG1 JPH1 NRXN3 LEF1 PDZRN3 TBX5

5.63e-071951107a486a7acea0e91048cc48afa0dbd3926d30bc217
ToppCelltumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass

HGF FMO3 ANK2 FEZ1 LRP1 PDZRN3 TBX5

6.24e-0719811072d7842f352273b6b823c86eb548b9f4a4cddf0ae
ToppCellLPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type

ENPP6 HGF ANK2 CPZ PXDNL LRP1 PDZRN3

6.45e-071991107211c3a08f2d484ab7a3368006767289088f0d957
ToppCellLPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type

ENPP6 HGF ANK2 CPZ PXDNL LRP1 PDZRN3

6.45e-0719911071a0add79f4e34078b3475eb11c85a4234bda197c
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

ENPP6 HGF ANK2 PXDNL LRP1 PDZRN3 TBX5

6.67e-0720011079b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCellControl_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type

KIAA0408 ENPP6 HGF PXDNL LRP1 PDZRN3 TBX5

6.67e-07200110764ae5cf6cb4fc94cf1052abd82648f6b8e6445fe
ToppCellParenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

HGF ANK2 GAS7 ADRA1A LRP1 PDZRN3 TBX5

6.67e-072001107cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCellBronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

HGF ANK2 GAS7 ADRA1A LRP1 PDZRN3 TBX5

6.67e-072001107cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCellLPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type

ENPP6 HGF ANK2 PXDNL LRP1 PDZRN3 TBX5

6.67e-072001107a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCellParenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

HGF ANK2 GAS7 ADRA1A LRP1 PDZRN3 TBX5

6.67e-072001107311fab076f2ceb258e3970eb21e39344b894042a
ToppCellControl_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type

KIAA0408 ENPP6 HGF PXDNL LRP1 PDZRN3 TBX5

6.67e-072001107a1fc74c1b27e104895910bc7cdce7ba33d30df7e
ToppCellBiopsy_Other_PF-Mesenchymal|Biopsy_Other_PF / Sample group, Lineage and Cell type

HGF ANK2 HEPH MEST FEZ1 PDZRN3 TBX5

6.67e-072001107d6fcdd48858b53b5a8d18ae14b2dc4d9af41b070
ToppCellControl_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type

KIAA0408 ENPP6 HGF ANK2 PXDNL LRP1 PDZRN3

6.67e-072001107bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCellLPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

KIAA0408 ENPP6 NRXN3 PXDNL ADAMTS16 TMEM131L

5.20e-061771106b7fee75de7e96924af488a5baa2334711889ae7c
ToppCellControl-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ENPP6 GAS7 ADRA1A PXDNL LRP1 PDZRN3

5.72e-06180110608ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCellControl-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ENPP6 GAS7 ADRA1A PXDNL LRP1 PDZRN3

5.72e-0618011069b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4
ToppCellControl-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ENPP6 GAS7 ADRA1A PXDNL LRP1 PDZRN3

5.91e-0618111069e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9
ToppCellfacs-Marrow-T-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HGF CYP2E1 L1CAM GAB2 PLG MAP4K4

5.91e-0618111067286700396676fdc41d9723979b8b408177aceb9
ToppCell10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue

ASH1L CHD2 JMJD1C FAAH2 TMEM131L LEF1

5.91e-061811106f2315414e714ac86211546a935660c4be6e85f1b
ToppCelldroplet-Limb_Muscle-nan-24m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

L1CAM MBP ADGRB1 GAS7 ATL1 INSYN2B

6.90e-061861106ea936e66ae4b7b40564711fad60ac0137327995f
ToppCellAdult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor

HGF MEST ADRA1A FEZ1 PDZRN3 TBX5

7.12e-061871106e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCell10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue

ASH1L CHD2 SIK3 JMJD1C NF1 TMEM131L

7.34e-061881106ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCellfacs-Pancreas-Endocrine-3m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HGF CACNA2D2 MEST CSRNP3 AUTS2 INSYN2B

7.57e-061891106fcc3713e8200d51074f709f3360fb36efb0a639f
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ENPP6 HGF FEZ1 PXDNL LRP1 PDZRN3

7.80e-061901106841cd55861b43578d704418b9bc0af2e8b88323a
ToppCell10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue

ASH1L CHD2 SIK3 JMJD1C FAAH2 TMEM131L

8.28e-06192110647646d7e4990be85072987f92bf18d52f8da752e
ToppCellLPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ENPP6 ANK2 CPZ FEZ1 LRP1 PDZRN3

8.28e-061921106ee085e04d5dcfb657522484ed20b8c1ddeccfe0c
ToppCellPND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PAPPA2 ANK2 PRAG1 JPH1 PDZRN3 TBX5

8.53e-061931106f25bdd10ef531b8d8441ea84573078b4b1b0f105
ToppCellE18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CYP2E1 JPH1 NRXN3 LEF1 PDZRN3 TBX5

9.04e-0619511062414b158dc7bdec43a9671544bfb7ffc5f5168fd
ToppCellPND01-Mesenchymal-Mesenchymal_myocytic|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CYP2E1 JPH1 NRXN3 LEF1 PDZRN3 TBX5

9.31e-061961106acbb493dbb49a33f20cf11106363f7ed51209706
ToppCell367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells)

HGF FMO3 MEST FEZ1 PDZRN3 TBX5

9.86e-061981106a9afedbc0556faf4a46f7bf28f4a9adb3bc859d8
ToppCell367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells)

HGF FMO3 MEST FEZ1 PDZRN3 TBX5

9.86e-0619811067b5350768f306ec528e271d2ac4470bf668ec6f0
ToppCellBiopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type

FMO3 CPZ HEPH ADRA1A FEZ1 PDZRN3

1.01e-0519911067a227c239afdaebcac84644d9b2653a5f1a4be71
ToppCellLPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

ENPP6 HGF ANK2 PXDNL LRP1 PDZRN3

1.01e-051991106a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

ANK2 MEST CSRNP3 LRP1 PDZRN3 TBX5

1.01e-05199110695d95e9b7bd3933188998ae94986213eb0f1e5ea
ToppCell343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells)

HGF FMO3 HEPH MEST LRP1 TBX5

1.01e-051991106f4b6c095cbe7a38b310adc49be4069e4d56e6a66
ToppCell343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells)

HGF FMO3 HEPH MEST LRP1 TBX5

1.01e-0519911069c6d1c328bfbb6547f4c7bb2a784576a56bd72af
ToppCellBronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ANK2 GAS7 ADRA1A LRP1 PDZRN3 TBX5

1.04e-052001106389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCellBronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

HGF GAS7 ADRA1A LRP1 PDZRN3 TBX5

1.04e-052001106e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCellTracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

HGF FMO3 GAS7 LRP1 PDZRN3 TBX5

1.04e-0520011063dd022e974fec7013ba18f333da63f58fbf2dd7c
ToppCellBiopsy_IPF-Mesenchymal|Biopsy_IPF / Sample group, Lineage and Cell type

HGF ANK2 CPZ MEST ADAMTS16 PDZRN3

1.04e-052001106bb605b373caf3f873dc1b87d712704568e0d6040
ToppCellParenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

HGF GAS7 ADRA1A LRP1 PDZRN3 TBX5

1.04e-05200110634f52003988ce6329d8deeee1ab875fa77e01e9d
ToppCellTracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

HGF GAS7 HEPH LRP1 PDZRN3 TBX5

1.04e-05200110658b38f9a484ee94191091a0659ed62ebed2d4a14
ToppCellControl-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ENPP6 CPZ ADRA1A PXDNL PDZRN3

1.48e-051251105b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b
ToppCell5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DRC7 ZNF703 ELFN2 HSF5 MEST

4.42e-051571105beab0ac47202266b04543c02cfcdda012375e879
ToppCell10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue

MBP ASH1L CHD2 FAAH2 TMEM131L

5.13e-051621105b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCellBronchial-10x5prime-Stromal-Schwann|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

ANK2 L1CAM HEPH NRXN3 FEZ1

5.13e-051621105afffecc6c504930554aafc12c5bffa53e3c5b016
ToppCelldroplet-Heart-nan-18m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRAG1 HEPH TMEM45B FEZ1 CLPTM1

6.10e-0516811052201ae834b53cbdc085f8f02607fa5b5bd911268
ToppCell368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

MBP ELFN2 PITX3 DISP1 TBX5

6.45e-051701105f0b0d2d0402de3ed7322284a599646db43475761
ToppCell368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

MBP ELFN2 PITX3 DISP1 TBX5

6.45e-051701105054360a3b05f5e41221c98b122d241b1affad26a
ToppCellfacs-Marrow-T-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CYP2E1 L1CAM CASK TLR3 LRP1

6.45e-051701105a78d9789c3e7c84a36e1bd380192d7aba4a4d443
ToppCellfacs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CYP2E1 L1CAM CASK TLR3 LRP1

6.45e-051701105ff68600b945b3a5437b14e5411b3db800d0ccbe5
ToppCellILEUM-inflamed-(9)_Enteric_neurons|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

ANK2 L1CAM GAS7 NRXN3 FEZ1

8.02e-051781105d9142151819afb0dc22bfb32a9c9dba5f553067d
ToppCellILEUM-inflamed-(9)_Neuro_cell|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

ANK2 L1CAM GAS7 NRXN3 FEZ1

8.02e-051781105611504b0a9e6318b18fba83787b03f9245c82252
ToppCellhuman_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

NRXN3 TMEM45B AUTS2 LEF1 TBX5

8.23e-05179110514fc8ccb6b215063d747643f47d780d2b237eb67
ToppCellE18.5-samps-Mesenchymal-Myofibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass

ANK2 GAS7 JPH1 NRXN3 TBX5

9.13e-051831105de08f9ea02b7244d5a8788064631d10f06565337
ToppCelldroplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1-41|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

KIAA0408 SKIDA1 GAS7 GAB2 NRXN3

9.13e-05183110507ca2786e62eca9feecf5e54a11864a960f7641a
ToppCellBAL-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters

ANG C5orf63 SKIDA1 SPATA2 MEST

9.61e-051851105e867ed55ab0df018f14bca824da09d36d83e12f9
ToppCellE16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass

ANK2 PRAG1 JPH1 LEF1 TBX5

9.86e-051861105e044b3428b7eacfdc72d0f57cdabaa1de04c74cd
ToppCelldroplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

KIAA0408 PAPPA2 CYP2E1 PDZRN3 TBX5

1.01e-0418711058bd635abdee5d5a12a3f7bf74eab4282e8e40741
ToppCelldroplet-Limb_Muscle-nan-24m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

L1CAM MBP ADGRB1 GAS7 INSYN2B

1.01e-041871105a0bd2b0ec9e73521c245037b1dd51ff8cf24cbf5
ToppCellFetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

HEPH LEF1 PDZRN3 DISP1 TBX5

1.01e-041871105c104fbfef2d0bef64077ac721edf2379fd59d547
ToppCelldroplet-Limb_Muscle-nan-24m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

L1CAM MBP ADGRB1 GAS7 INSYN2B

1.01e-041871105f2af79a20438108c814a73f9e24cd986d537237f
ToppCelldroplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

KIAA0408 PAPPA2 CYP2E1 PDZRN3 TBX5

1.01e-0418711053cb8cd7f7a4306ff74d1f7f9964014008ec1c6a0
ToppCelldroplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

L1CAM MBP ADGRB1 GAS7 INSYN2B

1.04e-041881105502045a39ffb1e92bd9499848368e8fa971edb88
ToppCell10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

KIAA0408 PAPPA2 ANK2 MEST ADAMTS16

1.06e-041891105eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0
ToppCell10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

KIAA0408 PAPPA2 ANK2 MEST ADAMTS16

1.06e-04189110540764f461b8aa1d3a2c5a30590b7fb9307d47d09
ToppCellLPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ANK2 GAS7 ADRA1A LRP1 PDZRN3

1.09e-04190110545df8fee00f8949937863159d7aa042e72748d9b
ToppCellfacs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PAPPA2 CYP2E1 PRAG1 PDZRN3 TBX5

1.09e-041901105c7bd087f36321cec61b98657433b4d19d135791f
ToppCellfacs-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PAPPA2 CYP2E1 PRAG1 PDZRN3 TBX5

1.09e-041901105834218fcc59df5e7e52de154272f3d55d81d0dac
ToppCellControl-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

KIAA0408 ENPP6 PXDNL LRP1 PDZRN3

1.12e-04191110514057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell3'-Child09-12-SmallIntestine-Neuronal-Glial_mature|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ANK2 L1CAM GAS7 NRXN3 FEZ1

1.14e-041921105ac507fd7cf3b3e521a15ef03bb4e81eb23807985
ToppCellFetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

PRAG1 HEPH PDZRN3 DISP1 TBX5

1.14e-04192110572881b280a415e65f87a80ca1369cbb0b722a0c4
ComputationalNeighborhood of MAGEA9

CYP2E1 CPZ SPATA2 HEPH ADRA1A NF1 ZNF33B LPGAT1 REPS2 TBX5

1.58e-044236310MORF_MAGEA9
Diseaseautism spectrum disorder (implicated_via_orthology)

ZNF280A TCF20 ASH1L CHD2 CASK NRXN3

1.60e-051521036DOID:0060041 (implicated_via_orthology)
DiseaseAcute kidney injury

ENPP6 ATL1 DISP1

8.98e-05251033HP_0001919
Diseaseisthmus cingulate cortex volume measurement

TCF20 PTCHD3 ADRA1A

1.01e-04261033EFO_0010310
Diseasesciatic neuropathy (is_implicated_in)

HGF LRP1

1.20e-0451032DOID:11446 (is_implicated_in)
Diseasefatty acid measurement

GAS7 SIK3 CEP128 PRAG1 JMJD1C CLPTM1 LPGAT1 PLG

1.49e-044361038EFO_0005110
Diseaseinfluenza A (H1N1)

ENPP6 ZNF703 CEP128 PXDNL

2.50e-04871034EFO_1001488
Diseasecognitive function measurement, self reported educational attainment

TCF20 CACNA2D2 JMJD1C FAM120A CSRNP3 PITX3 AUTS2

2.53e-043551037EFO_0004784, EFO_0008354
DiseaseSchizophrenia

CYP2E1 MBP ZDHHC8 ADRA1A NRXN3 FEZ1 TLR3 PITX3 LRP1 AUTS2 PLG

2.64e-0488310311C0036341
Diseaseepilepsy (implicated_via_orthology)

ANK2 CACNA2D2 L1CAM LRP1 MAP4K4

2.74e-041631035DOID:1826 (implicated_via_orthology)
DiseaseNeurodevelopmental Disorders

ANK2 ASH1L CHD2 CASK

3.22e-04931034C1535926
Diseaseunderweight body mass index status

ANK2 NRXN3

4.28e-0491032EFO_0005936
Diseasecholesteryl esters to total lipids in small LDL percentage

SIK3 CLPTM1 PLG

4.30e-04421033EFO_0022255
Diseasepolyunsaturated fatty acids to total fatty acids percentage

SIK3 JMJD1C PLG

7.19e-04501033EFO_0022303
Diseasepolyunsaturated fatty acids to monounsaturated fatty acids ratio

SIK3 JMJD1C PLG

7.62e-04511033EFO_0022302
Diseasefree cholesterol to total lipids in small LDL percentage

SIK3 JMJD1C PLG

8.52e-04531033EFO_0022286
Diseasehypertension (is_implicated_in)

HGF FMO3 ADRA1A MOV10

8.70e-041211034DOID:10763 (is_implicated_in)
DiseaseSpastic Paraplegia, Hereditary

L1CAM ATL1

1.07e-03141032C0037773
Diseasetriglycerides to total lipids in small LDL percentage

SIK3 JMJD1C PLG

1.17e-03591033EFO_0022337
Diseasecholesterol to total lipids in medium HDL percentage

SIK3 DDB2 PLG

1.22e-03601033EFO_0022237
Diseasetriglycerides in small VLDL measurement

SIK3 JMJD1C PLG

1.28e-03611033EFO_0022145
Diseasetriglycerides in small HDL measurement

SIK3 JMJD1C PLG

1.35e-03621033EFO_0022158
Diseasephospholipids in large VLDL measurement

SIK3 JMJD1C PLG

1.35e-03621033EFO_0022169
Diseasetriglycerides to total lipids in very large HDL percentage

SIK3 JMJD1C PLG

1.35e-03621033EFO_0022339
Diseaseresponse to antineoplastic agent, response to antimicrotubule agent

ADAMTS18 TMEM131L

1.40e-03161032EFO_0005260, GO_0097327
Diseasetriglycerides to total lipids in medium VLDL percentage

SIK3 JMJD1C PLG

1.41e-03631033EFO_0022335
Diseasecholesterol to total lipids in medium VLDL percentage

SIK3 JMJD1C PLG

1.41e-03631033EFO_0022239
Diseasefree cholesterol to total lipids in medium LDL percentage

SIK3 JMJD1C PLG

1.41e-03631033EFO_0022283
Diseasecholesteryl esters to total lipids in medium VLDL percentage

SIK3 JMJD1C PLG

1.47e-03641033EFO_0022253
Diseasetestosterone measurement

HGF ZNF703 FMO3 ANK2 CCDC85C SNUPN JMJD1C NF1 AUTS2 MINAR1 MYO15A LEF1

1.64e-03127510312EFO_0004908
Diseasetriglycerides to phosphoglycerides ratio

SIK3 JMJD1C PLG

1.76e-03681033EFO_0022327
Diseasefree cholesterol in large VLDL measurement

SIK3 JMJD1C PLG

1.76e-03681033EFO_0022265
Diseasetriglycerides to total lipids in very small VLDL percentage

SIK3 JMJD1C PLG

1.83e-03691033EFO_0022341
DiseaseS-6-hydroxywarfarin measurement

GALNT1 MBP GAS7 CCNY TMEM131L PLG

1.87e-033681036EFO_0803326
Diseasehydrocephalus (implicated_via_orthology)

L1CAM CCDC85C

1.99e-03191032DOID:10908 (implicated_via_orthology)
Diseasetriglycerides to total lipids in small HDL percentage

SIK3 JMJD1C PLG

2.07e-03721033EFO_0022336
Diseasemethylcobalamin deficiency type cblE

ANG MBP NRXN3

2.24e-03741033MONDO_0009354
Diseasefree cholesterol to total lipids in large LDL percentage

SIK3 JMJD1C PLG

2.24e-03741033EFO_0022280
Diseasetransient cerebral ischemia (biomarker_via_orthology)

ANG ANK2 MBP NF1

2.27e-031571034DOID:224 (biomarker_via_orthology)
Diseasefree cholesterol to total lipids in small VLDL percentage

SIK3 JMJD1C PLG

2.32e-03751033EFO_0022287
DiseaseAnophthalmia-microphthalmia syndrome

BCOR PITX3

2.43e-03211032cv:C5680330
Diseasemonounsaturated fatty acids; 16:1, 18:1 measurement

SIK3 JMJD1C PLG

2.60e-03781033EFO_0022187
Diseaseattention deficit hyperactivity disorder, autism spectrum disorder, intelligence

ATP23 CACNA2D2 PTPRU JMJD1C CSRNP3 AUTS2

2.76e-033981036EFO_0003756, EFO_0003888, EFO_0004337
Diseasemalignant astrocytoma (is_marker_for)

ADGRB1 NF1

2.91e-03231032DOID:3069 (is_marker_for)
DiseaseCerebral Astrocytoma

HGF NF1

3.44e-03251032C0750935
DiseaseIntracranial Astrocytoma

HGF NF1

3.44e-03251032C0750936
DiseaseAstrocytoma

HGF NF1

3.44e-03251032C0004114
DiseaseGrade I Astrocytoma

HGF NF1

3.44e-03251032C1704230
DiseaseSubependymal Giant Cell Astrocytoma

HGF NF1

3.44e-03251032C0205768
DiseaseMixed oligoastrocytoma

HGF NF1

3.44e-03251032C0547065
DiseasePilocytic Astrocytoma

HGF NF1

3.44e-03251032C0334583
DiseaseJuvenile Pilocytic Astrocytoma

HGF NF1

3.44e-03251032C0280783
DiseaseDiffuse Astrocytoma

HGF NF1

3.44e-03251032C0280785
DiseaseChildhood Cerebral Astrocytoma

HGF NF1

3.44e-03251032C0338070

Protein segments in the cluster

PeptideGeneStartEntry
SPSHPHMASQSGKRY

C5orf63

76

A6NC05
KGHFRQYPAHVSQPA

ZNF280A

76

P59817
LKYSFPGERPSHSLS

C2orf16

1941

Q68DN1
PTNFPIEKTREHYHA

CTDP1

646

Q9Y5B0
GFVEPSSVPYLHLHS

ASH1L

1126

Q9NR48
KVFSSGPDIHYDPHR

CEP128

851

Q6ZU80
HIGSLASVYHKPPNA

AP2B1

566

P63010
RRSLDNHGYVFKPPH

CACNA2D2

791

Q9NY47
SYSNIPHEGKHTPLY

C9orf129

66

Q5T035
ANVSKLHLHGSPRYP

ADGRB1

1281

O14514
SSKHALGYTLHPPSQ

ADRA1A

351

P35348
EPTYHLPSSQGHKRD

C8orf58

281

Q8NAV2
PLGETHHNDFYRKPL

ARL13B

396

Q3SXY8
INHHPPGQIARKYSS

CCNY

86

Q8ND76
SHGHYPASFSDPETR

FAM187A

361

A6NFU0
PTQPAADTYSEFHKH

BCOR

346

Q6W2J9
HTINAYHLDPRGPKS

DISP1

1171

Q96F81
SHVLYKRSTEPHAPG

ADAMTS16

201

Q8TE57
GYSPSHIPHASQSRE

ADAMTS18

226

Q8TE60
RYGHSKSPHFREKSP

RBM23

136

Q86U06
PSQKLGSAYLPSYHH

PDZRN3

851

Q9UPQ7
VFRAQPHSTSGLYPH

RFX6

706

Q8HWS3
FPSFLHYLPGSHRKV

CYP2E1

221

P05181
YTISPNPHFHLKLRD

PCDHB18P

116

Q96TA0
PLITYSDEHFSPGSH

LEF1

156

Q9UJU2
SPHATAKNGYTPLHI

ANK2

621

Q01484
HEPFGRIPHNKTYAR

ATP23

216

Q9Y6H3
TKHPDRFAYPIPHTT

CASK

761

O14936
RSKPSFHAPEPKAHY

MAP4K4

546

O95819
CSGHHVYPNLPKESF

FMO3

146

P31513
HFYETGAFPPSKGHK

LPGAT1

316

Q92604
HLSSIYAKPQGRLHP

M1AP

451

Q8TC57
SPYHNFDSVHKAPAS

NEDD1

196

Q8NHV4
EAPFHHSGSRKSLYG

MYO15A

211

Q9UKN7
NEIRSLFPGHPHSAY

LRP1

3876

Q07954
PPIHHSLERKEGSYS

JMJD1C

1211

Q15652
KYSGRHHIPNPSNGE

JPH1

531

Q9HDC5
HRSIPNGLHDPSSTY

CCDC85C

256

A6NKD9
HPQVEFHSYLKGPSQ

CSRNP3

526

Q8WYN3
SDLPGHSSYLHERPT

ATXN3L

301

Q9H3M9
HPRHYTFASGSPDNI

PLRG1

381

O43660
SLSLVHRYGHSAPPF

OR51F2

271

Q8NH61
RHSLFHSYPPAVSGI

AUTS2

576

Q8WXX7
HEGRSKRNYNPHFPL

KIAA0408

301

Q6ZU52
LHKPQSHLYGPGETA

L1CAM

336

P32004
KPQCFYGSSPHHLED

FEZ1

26

Q99689
THFLTQHYDAKPQGR

ANG

31

P03950
NSYSNIPHEGKHTPL

FAM120A

416

Q9NZB2
IPHEHSFLPSSYRGK

HGF

156

P14210
SLPTPHDDHFGTSYQ

HAUS5

211

O94927
HEYPHFSHRPSTLQA

OAS1

371

P00973
RGKASFLYSLPHRHP

DDB2

276

Q92466
SHGPYDSNQPHRKTK

NBPF1

756

Q3BBV0
KGSPYHTGQLHPAVR

PTPRU

861

Q92729
QKLSPTYPAAHHFRS

SMPD2

61

O60906
HYCGPQESKHSDPFR

POP1

891

Q99575
PHGASRPILTSYHFK

ITPRIPL1

436

Q6GPH6
ASPQHHLFGVYPSRA

PAPPA2

61

Q9BXP8
KPHTSSDLLAQFHYP

PXDNL

636

A1KZ92
TCSDRYNPGHLLPHK

FUCA2

276

Q9BTY2
HVGHVFRKATPYTFP

GALNT1

341

Q10472
KTYFPHFDLHPGSAQ

HBZ

41

P02008
AATHRHLYHQAFPTP

ATL1

531

Q8WXF7
SGLPPTFIRFSHHSY

CPZ

176

Q66K79
QGPSDHYRSFHTDKL

CHD2

1756

O14647
DYFKPGHPQALRVHS

DRC7

501

Q8IY82
HHVPLTRPFNFAYTG

FAAH2

461

Q6GMR7
LKNFASRPYSLHPHG

HEPHL1

116

Q6MZM0
HPARTAHYGSLPQKS

MBP

196

P02686
ASANHGHSPCYPERK

LINC01546

6

A6NGU7
GHHYGPASPQRKDAL

ENPP6

196

Q6UWR7
HQGSVLHPDYKTAFP

BICRA

1091

Q9NZM4
GAETPKQAFFHLYHP

SALL2

266

Q9Y467
GFGFSDKPRPHHYSI

MEST

106

Q5EB52
DKPRPHHYSIFEQAS

MEST

111

Q5EB52
AKQHASFSYPAVHGP

PITX3

271

O75364
SSISFPAYNHGRHPL

PTCHD3

281

Q3KNS1
SKSRLYPQAQHSHYP

PURG

26

Q9UJV8
QVFSPHPYPASLKAH

MINAR1

791

Q9UPX6
HGFYSLPKPSRHNTE

GAB2

246

Q9UQC2
VSTPSHDHSTYPLKG

HSF5

206

Q4G112
HDHSTYPLKGLDRTP

HSF5

211

Q4G112
FDHNYLKPLLTHSGP

SLC9A6

541

Q92581
GHPVAKILHAYNPSR

TMEM131L

106

A2VDJ0
EFLYSHGVPRTLSPH

TBX5

486

Q99593
SHGPYDSNQPHRKTK

NBPF12

756

Q5TAG4
STSGPHSHDYLPQER

MOV10

971

Q9HCE1
GSKHHSVPISIYRSP

NRXN3

61

Q9HDB5
HVEPKYSALHSTSPG

POU4F2

21

Q12837
HRSSLPPTVNGYHAS

GAS7

121

O60861
KNFATRPYTIHPHGV

HEPH

116

Q9BQS7
HGLPNKVHLSPTAYR

GUCY1B2

521

O75343
AAHLPQIFSKYPGSH

SKIDA1

166

Q1XH10
IHPYGHQPTAAFSKN

SIK3

1151

Q9Y2K2
RSFHNLSHLPPSYEA

SHISA7

296

A6NL88
HKQTHYSPGSTPLVG

SNUPN

261

O95149
SQSPHAHGYIPSKFP

PLG

211

P00747
IHVYFTKSGFHPDPR

CLPTM1

166

O96005
PLKYFSHTRKNSPLH

TMEM45B

26

Q96B21
RNDAHSLYHKRSPPA

SPATA2

361

Q9UM82
GLSRYHPYGKSHLST

ZNF703

541

Q9H7S9
PHYHGFPVRLFDTSS

TLR3

681

O15455
SLLFHQIPPSKDSHY

ZNF33B

261

Q06732
PHYQRVPLSHGYSKL

REPS2

201

Q8NFH8
YPIHHGDPSYRTLKE

NF1

2476

P21359
CHPPSIKHESYRGNA

TCF20

951

Q9UGU0
FHGQSFYSTRPPSIH

PILRB

76

Q9UKJ0
HFSYSLSPGNRHHPV

PRAG1

861

Q86YV5
PHHQLPREGSSSEYS

ZCCHC14

406

Q8WYQ9
HSPSYAGPKAVAFIH

ZDHHC8

681

Q9ULC8
PSLRHHNQDKFPASY

TIGD5

301

Q53EQ6
PYELHQRTHTGEKPY

ZNF487

341

B1APH4
FLSPPYKESSHHPLQ

ELFN2

601

Q5R3F8
GKTQATRHHLPPTYS

INSYN2B

66

A6NMK8